INTEGRA LIFESCIENCES HOLDINGS CORP Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (Deprecated 2018-01-31)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (Deprecated 2018-01-31) of $7.91 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-26.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet · last filed 2018-04-26
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $7.91M, a 1250.34% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was -$2.81M, a 251.32% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $297.00K, a 51.94% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was -$1.50M.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion, net (deprecated 2018-01-31) for fiscal 2017 was -$3.42M, a 283.06% decline from fiscal 2016.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion, net (deprecated 2018-01-31) for fiscal 2016 was $1.87M.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion, net (deprecated 2018-01-31) for fiscal 2015 was -$25.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion, net (deprecated 2018-01-31) for fiscal 2014 was -$206.00K.
| Period end | Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (Deprecated 2018-01-31) 3 month | Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (Deprecated 2018-01-31) 6 month | Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (Deprecated 2018-01-31) 9 month | Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $7.91M 10-Q · filed 2018-04-26 | $5.11M derived: sum of 2 quarters · filed 2018-04-26 | $5.40M derived: sum of 3 quarters · filed 2018-04-26 | $3.90M derived: sum of 4 quarters · filed 2018-04-26 |
| 2017-12-31 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$2.51M derived: sum of 2 quarters · filed 2018-03-01 | -$4.01M derived: sum of 3 quarters · filed 2018-03-01 | -$3.42M 10-K · filed 2018-03-01 |
| 2017-09-30 | $297.00K 10-Q · filed 2017-10-26 | -$1.20M derived: sum of 2 quarters · filed 2017-10-26 | -$618.00K 10-Q · filed 2017-10-26 | $1.24M derived: sum of 4 quarters · filed 2018-04-26 |
| 2017-06-30 | -$1.50M 10-Q · filed 2017-07-26 | -$914.00K 10-Q · filed 2017-07-26 | $941.00K derived: sum of 3 quarters · filed 2018-04-26 | $1.56M derived: sum of 4 quarters · filed 2018-04-26 |
| 2017-03-31 | $586.00K 10-Q · filed 2018-04-26 | $2.44M derived: sum of 2 quarters · filed 2018-04-26 | $3.06M derived: sum of 3 quarters · filed 2018-04-26 | $2.46M derived: sum of 4 quarters · filed 2018-04-26 |
| 2016-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $2.47M derived: sum of 2 quarters · filed 2018-03-01 | $1.87M derived: sum of 3 quarters · filed 2018-03-01 | $1.87M 10-K · filed 2018-03-01 |
| 2016-09-30 | $618.00K 10-Q · filed 2017-10-26 | $16.00K derived: sum of 2 quarters · filed 2017-10-26 | $16.00K 10-Q · filed 2017-10-26 | |
| 2016-06-30 | -$602.00K 10-Q · filed 2017-07-26 | -$602.00K 10-Q · filed 2017-07-26 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | -$7.00K derived: sum of 3 quarters · filed 2017-02-23 | -$25.00K 10-K · filed 2017-02-23 |
| 2015-09-30 | $0.00 10-Q · filed 2016-10-28 | -$7.00K derived: sum of 2 quarters · filed 2016-10-28 | -$25.00K 10-Q · filed 2016-10-28 | -$52.00K derived: sum of 4 quarters · filed 2016-10-28 |
| 2015-06-30 | -$7.00K 10-Q · filed 2016-07-28 | -$25.00K 10-Q · filed 2016-07-28 | -$52.00K derived: sum of 3 quarters · filed 2016-07-28 | -$61.00K derived: sum of 4 quarters · filed 2016-07-28 |
| 2015-03-31 | -$18.00K 10-Q · filed 2016-04-27 | -$45.00K derived: sum of 2 quarters · filed 2016-04-27 | -$54.00K derived: sum of 3 quarters · filed 2016-04-27 | -$114.00K derived: sum of 4 quarters · filed 2016-04-27 |
| 2014-12-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$36.00K derived: sum of 2 quarters · filed 2016-02-26 | -$96.00K derived: sum of 3 quarters · filed 2016-02-26 | -$206.00K 10-K · filed 2016-02-26 |
| 2014-09-30 | -$9.00K 10-Q · filed 2015-11-04 | -$69.00K derived: sum of 2 quarters · filed 2015-11-04 | -$179.00K 10-Q · filed 2015-11-04 | -$271.00K derived: sum of 4 quarters · filed 2015-11-04 |
| 2014-06-30 | -$60.00K 10-Q · filed 2015-07-31 | -$169.00K 10-Q · filed 2015-07-31 | -$262.00K derived: sum of 3 quarters · filed 2015-07-31 | -$539.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2014-03-31 | -$109.00K 10-Q · filed 2015-05-01 | -$202.00K derived: sum of 2 quarters · filed 2015-05-01 | -$479.00K derived: sum of 3 quarters · filed 2015-05-01 | -$209.00K derived: sum of 4 quarters · filed 2015-05-01 |
| 2013-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$370.00K derived: sum of 2 quarters · filed 2015-02-27 | -$100.00K derived: sum of 3 quarters · filed 2015-02-27 | -$110.00K 10-K · filed 2015-02-27 |
| 2013-09-30 | -$277.00K 10-Q · filed 2014-11-07 | -$7.00K derived: sum of 2 quarters · filed 2014-11-07 | -$17.00K 10-Q · filed 2014-11-07 | $14.00K derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | $270.00K 10-Q · filed 2014-08-05 | $261.00K 10-Q/A · filed 2013-08-02 | $291.00K derived: sum of 3 quarters · filed 2014-08-05 | -$462.00K derived: sum of 4 quarters · filed 2014-08-05 |
| 2013-03-31 | -$9.00K 10-Q · filed 2014-05-01 | $21.00K derived: sum of 2 quarters · filed 2014-06-20 | -$732.00K derived: sum of 3 quarters · filed 2014-06-20 | -$1.83M derived: sum of 4 quarters · filed 2014-06-20 |
| 2012-12-31 | $30.00K derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | -$723.00K derived: sum of 2 quarters · filed 2014-06-20 | -$1.82M derived: sum of 3 quarters · filed 2014-06-20 | -$2.06M 8-K · filed 2014-06-20 |
| 2012-09-30 | -$753.00K 10-Q · filed 2013-10-30 | -$1.85M derived: sum of 2 quarters · filed 2013-10-30 | -$2.09M 10-Q · filed 2013-10-30 | |
| 2012-06-30 | -$1.10M 10-Q/A · filed 2013-08-02 | -$1.34M 10-Q/A · filed 2013-08-02 | ||
| 2012-03-31 | -$285.00K 10-Q · filed 2013-05-02 | |||
| 2011-12-31 | -$6.31M 10-K · filed 2013-02-26 | |||
| 2010-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $4.22M derived: sum of 2 quarters · filed 2012-02-27 | $2.49M 10-K · filed 2012-02-27 | |
| 2010-09-30 | $786.00K 10-Q · filed 2011-10-31 | -$949.00K 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |